CSAM HEALTH GROUP NK 10
Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution. It also provides con… Read more
CSAM HEALTH GROUP NK 10 (6Q1) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, CSAM HEALTH GROUP NK 10 (6Q1) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CSAM HEALTH GROUP NK 10 - Net Assets Trend (None–None)
This chart illustrates how CSAM HEALTH GROUP NK 10's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CSAM HEALTH GROUP NK 10 (None–None)
The table below shows the annual net assets of CSAM HEALTH GROUP NK 10 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to CSAM HEALTH GROUP NK 10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
CSAM HEALTH GROUP NK 10 Competitors by Market Cap
The table below lists competitors of CSAM HEALTH GROUP NK 10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Viking Supply Ships AB (publ)
ST:VSSAB-B
|
$26.99 Million |
|
YES24 Co.Ltd
KQ:053280
|
$27.00 Million |
|
DAEMO Engineering Co. Ltd
KQ:317850
|
$27.00 Million |
|
ICBC Turkey Bank AS
IS:ICBCT
|
$27.00 Million |
|
Solar Foods Oyj
F:H4N
|
$26.98 Million |
|
Duckshin Housing Co. Ltd
KQ:090410
|
$26.98 Million |
|
Kutahya Porselen Sanayi AS
IS:KUTPO
|
$26.97 Million |
|
Meyer Burger Technology AG
PINK:MYRBY
|
$26.94 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CSAM HEALTH GROUP NK 10's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares CSAM HEALTH GROUP NK 10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently CSAM HEALTH GROUP NK 10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares CSAM HEALTH GROUP NK 10's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CSAM HEALTH GROUP NK 10 (6Q1) | €- | N/A | N/A | $26.98 Million |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |